Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA1 | P42261 | 6/20 | 0.56 |
| ▸ | GRIA2 | P42262 | 6/20 | 0.56 |
| ▸ | GRIA4 | P48058 | 6/20 | 0.56 |
| ▸ | GRIK5 | Q16478 | 6/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.56 |
| ▸ | BLM | P54132 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | DUT | P33316 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (S)-Willardiine SCHEMBL401191 | 1.00 | GRIA1 (0.56) | GRIA1GRIA2GRIA4GRIK5CYP1A2 | |
| SCHEMBL666953 | 0.86 | GRM5 (0.50) | GRIA1GRIA2GRIA4GRIK5CYP1A2 | |
| SCHEMBL3635924 | 0.81 | DUT (0.57) | KMT2AKDM4EPKMDUTALDH1A1 | |
| SCHEMBL7136481 | 0.81 | PKM (0.56) | PKMDUTALDH1A1LMNA | |
| SCHEMBL5001166 | 0.78 | DUT (0.51) | GRIA1GRIA2GRIA4GRIK5CYP1A2 | |
| SCHEMBL667078 | 0.78 | PKM (0.61) | PKMDUTALDH1A1LMNA | |
| SCHEMBL14478216 | 0.78 | PKM (0.61) | PKMDUTALDH1A1LMNA | |
| SCHEMBL23873265 | 0.78 | PKM (0.60) | PKMDUTALDH1A1LMNA | |
| SCHEMBL4311546 | 0.77 | DUT (0.50) | KMT2AKDM4EPKMDUTALDH1A1 | |
| SCHEMBL5000786 | 0.77 | DUT (0.50) | KMT2AKDM4EPKMDUTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140057850-A1 | PEPTIDE FOR USE IN THE TREATMENT OF SKIN CONDITIONS | ORGANOBALANCE GMBH (DE) | 2014-02-27 | — | — | US | claimed |
| EP-2673288-A1 | PEPTIDE FOR USE IN THE TREATMENT OF SKIN CONDITIONS | Organo Balance GmbH (DE) | 2013-12-18 | — | — | EP | claimed |
| WO-2012107244-A1 | PEPTIDE FOR USE IN THE TREATMENT OF SKIN CONDITIONS | ORGANOBALANCE GMBH (DE) | 2012-08-16 | — | — | WO | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| CN-118324862-A | Acetylcholine receptor inhibiting peptides and uses thereof | 思亲美有限公司 | 2024-07-12 | — | — | CN | disclosed |
| US-20240158722-A1 | METHODS OF FACILITATING REMOVAL OF A FINGERPRINT | TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) | 2024-05-16 | — | — | US | disclosed |
| EP-4352221-A1 | MAP4K4 INHIBITORS AND METHODS OF SYNTHESIS AND USE THEREOF | The Board Of Regents Of The University Of Oklahoma (US) | 2024-04-17 | — | — | EP | disclosed |
| US-20240083946-A1 | SELF-ASSEMBLING PEPTIDES, NANOFIBERS, AND METHODS OF USE | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA | 2024-03-14 | — | — | US | disclosed |
| EP-4311399-A2 | SELF-ASSEMBLING PEPTIDES, NANOFIBERS, AND METHODS OF USE | The Board Of Regents Of The University Of Oklahoma (US) | 2024-01-31 | — | — | EP | disclosed |
| US-11834635-B2 | Methods of facilitating removal of a fingerprint | TOYOTA MOTOR CORPORATION (JP) | 2023-12-05 | — | — | US | disclosed |
| US-20230374420-A1 | BIOACTIVE MATERIALS | TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) | 2023-11-23 | — | — | US | disclosed |
| US-20230340296-A1 | COATINGS CONTAINING ENZYME FOR STABLE SELF-CLEANING OF ORGANIC STAINS | TOYOTA MOTOR CORPORATION (JP) | 2023-10-26 | — | — | US | disclosed |
| WO-2001068145-A2 | PEPTIDASE-CLEAVABLE, TARGETED ANTINEOPLASTIC DRUGS AND THEIR THERAPEUTIC USE | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-09-20 | — | — | WO | disclosed |
| WO-2001064678-A2 | INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-09-07 | — | — | WO | disclosed |
| WO-2001040262-A1 | ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-06-07 | — | — | WO | disclosed |
| US-6191168-B1 | BACTERICIDES | Rubenstein, Edward | 2001-02-20 | — | — | US | disclosed |
| WO-2001002424-A2 | PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE | DU PONT PHARMACEUTICALS COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | disclosed |
| EP-0787010-A1 | AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-06 | — | — | EP | disclosed |
| WO-1996012499-A1 | AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140057850-A1 | PEPTIDE FOR USE IN THE TREATMENT OF SKIN CONDITIONS | NGLY1, FPR3, CUTA | GRIA1 3978/4885GRIA2 4413/4885GRIA4 3319/4885 |
| US-20230340296-A1 | COATINGS CONTAINING ENZYME FOR STABLE SELF-CLEANING OF ORGANIC STAINS | BCHE, ACHE, JMJD7 | GRIA1 3175/4885GRIA2 3203/4885GRIA4 3565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.